Mark L. Smith

593 total citations
9 papers, 468 citations indexed

About

Mark L. Smith is a scholar working on Biotechnology, Plant Science and Molecular Biology. According to data from OpenAlex, Mark L. Smith has authored 9 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Biotechnology, 5 papers in Plant Science and 4 papers in Molecular Biology. Recurrent topics in Mark L. Smith's work include Transgenic Plants and Applications (7 papers), Plant Virus Research Studies (5 papers) and Bacteriophages and microbial interactions (3 papers). Mark L. Smith is often cited by papers focused on Transgenic Plants and Applications (7 papers), Plant Virus Research Studies (5 papers) and Bacteriophages and microbial interactions (3 papers). Mark L. Smith collaborates with scholars based in United States and France. Mark L. Smith's co-authors include Kenneth E. Palmer, Michael L. Shuler, Hugh S. Mason, Alison A. McCormick, Long V. Nguyen, John A. Lindbo, Gregory P. Pogue, Paul Brosio, Amanda B. Lasnik and Thomas H. Turpen and has published in prestigious journals such as Cancer Research, Virology and Biotechnology and Bioengineering.

In The Last Decade

Mark L. Smith

9 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark L. Smith United States 8 284 274 180 146 92 9 468
Yulia Meshcheriakova United Kingdom 12 215 0.8× 184 0.7× 184 1.0× 126 0.9× 62 0.7× 16 412
Stephen L. Hoffman United States 6 159 0.6× 218 0.8× 144 0.8× 59 0.4× 75 0.8× 9 418
Tomáš Moravec Czechia 14 274 1.0× 269 1.0× 399 2.2× 73 0.5× 56 0.6× 60 586
Johanna Marsian United Kingdom 6 176 0.6× 165 0.6× 153 0.8× 76 0.5× 48 0.5× 6 355
Eugenia S. Mardanova Russia 14 239 0.8× 306 1.1× 161 0.9× 50 0.3× 96 1.0× 35 513
Abel Gutiérrez‐Ortega Mexico 13 115 0.4× 210 0.8× 228 1.3× 29 0.2× 83 0.9× 43 575
Liz Nicholson United Kingdom 9 686 2.4× 627 2.3× 287 1.6× 51 0.3× 153 1.7× 10 772
Pierre‐Olivier Lavoie Canada 10 469 1.7× 426 1.6× 209 1.2× 24 0.2× 166 1.8× 20 643
Frank Thieme Germany 12 190 0.7× 258 0.9× 825 4.6× 34 0.2× 74 0.8× 20 1.1k
Emmanuel Margolin South Africa 12 256 0.9× 216 0.8× 89 0.5× 18 0.1× 156 1.7× 20 410

Countries citing papers authored by Mark L. Smith

Since Specialization
Citations

This map shows the geographic impact of Mark L. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Smith more than expected).

Fields of papers citing papers by Mark L. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Smith. The network helps show where Mark L. Smith may publish in the future.

Co-authorship network of co-authors of Mark L. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Smith. A scholar is included among the top collaborators of Mark L. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Smith. Mark L. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Smith, Mark L., Wayne P. Fitzmaurice, Thomas H. Turpen, & Kenneth E. Palmer. (2009). Display of Peptides on the Surface of Tobacco Mosaic Virus Particles. Current topics in microbiology and immunology. 332. 13–31. 38 indexed citations
2.
Smith, Mark L., John A. Lindbo, Paul Brosio, et al.. (2006). Modified Tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications. Virology. 348(2). 475–488. 139 indexed citations
3.
McCormick, Alison A., et al.. (2006). TMV-peptide fusion vaccines induce cell-mediated immune responses and tumor protection in two murine models. Vaccine. 24(40-41). 6414–6423. 59 indexed citations
4.
Palmer, Kenneth E., Kathleen M. Hanley, Alison A. McCormick, et al.. (2006). Protection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopes. Vaccine. 24(26). 5516–5525. 65 indexed citations
6.
McCormick, Alison A., et al.. (2004). Using tobacco mosaic virus epitope display to enhance papillomavirus L2 antigen presentation. Cancer Research. 64. 290–290. 1 indexed citations
7.
Smith, Mark L., et al.. (2003). Structural characterization of plant-derived hepatitis B surface antigen employed in oral immunization studies. Vaccine. 21(25-26). 4011–4021. 37 indexed citations
8.
Smith, Mark L., et al.. (2002). Factors Important in the Extraction, Stability and in Vitro Assembly of the Hepatitis B Surface Antigen Derived from Recombinant Plant Systems. Biotechnology Progress. 18(3). 538–550. 26 indexed citations
9.
Smith, Mark L., Hugh S. Mason, & Michael L. Shuler. (2002). Hepatitis B surface antigen (HBsAg) expression in plant cell culture: Kinetics of antigen accumulation in batch culture and its intracellular form. Biotechnology and Bioengineering. 80(7). 812–822. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026